Urolithin A While Pregnant or Breastfeeding

Here is the plain answer first: urolithin A has not been studied in pregnancy or breastfeeding, so there is no safety data to rely on. The standard, cautious guidance is to avoid it during pregnancy and while nursing unless your own doctor or midwife specifically advises otherwise. This page explains the reasoning honestly and offers a sensible path forward.

The short answer for pregnancy and breastfeeding

Urolithin A is a gut postbiotic — a compound the microbiome makes from ellagitannins in pomegranate, walnuts, and berries — and its studied role is to support mitophagy, the cellular process that recycles worn-out mitochondria. That is interesting science for healthy-aging adults, but the clinical trials behind it were not designed with pregnancy in mind. They enrolled older and middle-aged non-pregnant adults, and pregnant or breastfeeding participants are, appropriately, excluded from this kind of research. The result is a genuine evidence gap: no one has measured what urolithin A does during pregnancy, in a developing baby, or in breast milk.

When there is no data, the responsible default in maternal health is caution. That is why the sensible guidance is to hold off on urolithin A during pregnancy and lactation unless a qualified clinician who knows your situation tells you it is appropriate. This is not a statement that urolithin A is dangerous in these stages — it is a statement that we do not know, and that not knowing is itself a reason to wait.

Why caution is the default during pregnancy

Pregnancy is a uniquely sensitive window. The placenta transfers many compounds to the developing baby, organ systems are forming on a strict timeline, and the margin for the unknown is small. For that reason, professional and public-health bodies consistently advise pregnant people to be conservative about supplements that have not been specifically shown to be safe in pregnancy. Public-health guidance from sources such as the NIH Office of Dietary Supplements and Mayo Clinic Health System stresses that dietary supplements are not tested or approved the way medications are, and that a pregnant person should talk with their healthcare provider before taking any supplement rather than assuming a product is safe simply because it is available over the counter.

Two facts compound this. First, dietary supplements in the United States are not reviewed by the FDA for safety or effectiveness before they reach shelves the way drugs are. Second, natural does not mean risk-free — plenty of naturally derived compounds have meaningful biological effects, which is precisely why they can matter in pregnancy. Put together, an ingredient with no pregnancy data and real cellular activity is exactly the kind of thing to set aside until after this chapter, unless your provider says otherwise.

What the human evidence does and does not cover

To be transparent about the science, it helps to see the boundaries of what has actually been tested — and to note that none of it involved pregnancy.

Human trials, all in non-pregnant adults

The first-in-human study (Andreux and colleagues, Nature Metabolism, 2019) established safety and tolerability up to 1,000 mg per day and a mitochondrial gene-expression signature in older adults. A roughly four-month trial (Liu and D'Amico and colleagues, JAMA Network Open, 2022) found improvements in muscle endurance in older adults, and Singh and colleagues (Cell Reports Medicine, 2022) reported gains in muscle strength and exercise performance in middle-aged adults across 500 mg and 1,000 mg arms. Newer work includes a 2025 Nature Aging randomized trial showing support for immune-cell mitochondrial health in midlife adults over about 28 days, and a 2024 trial in the Journal of the International Society of Sports Nutrition on recovery markers in resistance-trained men. Every one of these studies was conducted in non-pregnant adults, and the systematic review 'Targeting aging with urolithin A in humans' (Ageing Research Reviews, 2024) describes the overall evidence base as still emerging, drawn from short trials of modest size.

Preclinical research does not fill the gap

The foundational preclinical work (Ryu and colleagues, Nature Medicine, 2016) demonstrated mitophagy, extended lifespan in C. elegans, and improved rodent muscle function, and later animal and cell studies have explored joint, skin, gut, brain, and heart tissue. Preclinical findings are hypothesis-generating; they cannot substitute for pregnancy-specific human safety data, and they should not be read as reassurance for use during pregnancy or breastfeeding.

Not a treatment — see your doctor. Nothing here is medical advice for your pregnancy. Urolithin A is not a treatment for any pregnancy-related condition, and decisions about what to take while expecting or nursing should be made with your obstetrician, midwife, or qualified healthcare provider.

What to do instead right now

If your underlying goal was to support your energy, strength, or overall health, pregnancy and the postpartum period have their own well-established playbook — one that is actually studied for this stage of life.

Lean on pregnancy-specific nutrition

A prenatal vitamin with adequate folate or folic acid, along with the nutrients your provider recommends such as iron, iodine, choline, and omega-3 DHA where appropriate, is the evidence-based foundation. These have been studied specifically in pregnancy, which is exactly what urolithin A has not.

Get your dietary sources of the precursor naturally

Because urolithin A is produced by the microbiome from ellagitannins, whole foods like pomegranate, walnuts, strawberries, and raspberries supply those precursors as part of a normal, varied diet — an approach that fits comfortably within standard pregnancy nutrition. Our overview of foods high in urolithin A covers these sources if you are curious.

Prioritize the basics

Rest, gentle activity approved by your provider, hydration, and regular prenatal care do more for how you feel than any single supplement. Save the optional additions for after you and your clinician have the full picture.

After pregnancy and breastfeeding

Many people simply plan to revisit urolithin A once they are no longer pregnant or nursing. That is a reasonable path. When that time comes, the clinically studied range is 500 to 1,000 mg per day, the human safety record in non-pregnant adults is reassuring, and a quick check-in with your clinician — particularly while breastfeeding — is the right way to confirm timing. To understand the ingredient before you restart, our urolithin A guide explains the mechanism and the evidence, best urolithin A gummies helps you evaluate products, and urolithin A dosage walks through the studied amounts. There is no rush; the safest sequence is to wait, ask, and then decide with your provider.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.